DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection

Virology

Volumn 255, Issue 2, 1999, Pages 269-278

  Hooper, J W ^a   Kamrud, K I ^a   Elgh, F ^a,b   Custer, D ^a   Schmaljohn, C S ^a  

^a U States Army Med Res Inst I   (United States)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HANTAVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION; VIRUS HEMORRHAGIC FEVER;

ANIMALIA; CAVIA PORCELLUS; CRICETINAE; HANTAVIRUS; MESOCRICETUS AURATUS; RNA VIRUSES; SEOUL VIRUS; SUS SCROFA;

EID: 0033558775     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9586     Document Type: Article

References (33)

1. Arikawa J., Lapenotiere H. F., Iacono-Connors L., Wang M. L., Schmaljohn C. S. Coding properties of the S and the M genome segments of Sapporo rat virus: Comparison to other causative agents of hemorrhagic fever with renal syndrome. Virology. 176:1990;114-125.
2. Arikawa J., Schmaljohn A. L., Dalrymple J. M., Schmaljohn C. S. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J. Gen. Virol. 70:1989;615-624.
3. Arikawa J., Yao J. S., Yoshimatsu K., Takashima I., Hashimoto N. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch. Virol. 126:1992;271-281.
4. Asada H., Balachandra K., Tamura M., Kondo K., Yamanishi K. Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. J. Gen. Virol. 70:1989;819-825.
5. Chu Y. K., Jennings G. B., Schmaljohn C. S. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J. Virol. 69:1995;6417-6423.
6. Dantas J. R. Jr., Okuno Y., Asada H., Tamura M., Takahashi M., Tanishita O., Takahashi Y., Kurata T., Yamanishi K. Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. Virology. 151:1986;379-384.
7. Eisenbraun M. D., Fuller D. H., Haynes J. R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:1993;791-797.
8. Elgh F., Lundkvist A., Alexeyev O. A., Stenlund H., Avsic-Zupanc T., Hjelle B., Lee H. W., Smith K. J., Vainionpaa R., Wiger D., Wadell G., Juto P. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J. Clin. Microbiol. 35:1997;1122-1130.
9. Elliott L. H., Kiley M. P., McCormick J. B. Hantaan virus: identification of virion proteins. J. Gen. Virol. 65:1984;1285-1293.
10. Feltquate D. M., Heaney S., Webster R. G., Robinson H. L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
11. Gregoriadis G. Genetic vaccines: Strategies for optimization. Pharm. Res. 15:1998;661-670.
12. Kamrud K. I., Powers A. M., Higgs S., Olson K. E., Blair C. D., Carlson J. O., Beaty B. J. The expression of chloramphenicol acetyltransferase in mosquitoes and mosquito cells using a packaged Sindbis replicon system. Exp. Parasitol. 81:1995;394-403.
13. Kitamura T., Morita C., Komatsu T., Sugiyama K., Arikawa J., Shiga S., Takeda H., Akao Y., Imaizumi K., Oya A., Hashimoto N., Urasawa S. Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system. Jpn. J. Med. Sci. Biol. 36:1983;17-25.
14. Lee H., Ahn C., Song J., Baek L., Seo T., Park S. Field trial of an inactivated vaccine against hemorrhagic fever with renal syndrome in humans. Arch. Virol. Suppl 1:1990;35-47.
15. Lu Q., Zhu Z., Weng J. Immune responses to inactivated vaccine in people naturally infected with hantaviruses. J. Med. Virol. 49:1996;333-335.
16. Lundkvist Å., Kallio-Kokko H., Brus-Sjölander K., Lankinen H., Niklasson B., Vaheri A., Vapalahti O. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology. 216:1996;397-406.
17. Lundkvist Å., Niklasson B. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Arch. Virol. 126:1992;93-105.
18. National Institutes of Health, 1996, Guide for the Care and Use of Laboratory Animals, National Institutes of Health, Bethesda, MD.
19. Pensiero M. N., Jennings G. B., Schmaljohn C. S., Hay J. Expression of the Hantaan virus M genome segment by using a vaccinia virus recombinant. J. Virol. 62:1988;696-702.
20. Pertmer T. M., Eisenbraun M. D., McCabe D., Prayaga S. K., Fuller D. H., Haynes J. R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427-1430.
21. Robinson H. L., Torres C. A. DNA vaccines. Semin. Immunol. 9:1997;271-283.
22. Ruo S. L., Sanchez A., Elliott L. H., Brammer L. S., McCormick J. B., Fisher-Hoch S. P. Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch. Virol. 119:1991;1-11.
23. Schmaljohn C. S. Molecular Biology of Hantaviruses: The Bunyaviridae. 1996;Plenum Press, New York. p. 63-90.
24. Schmaljohn C. S., Chu Y. K., Schmaljohn A. L., Dalrymple J. M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 64:1990;3162-3170.
25. Schmaljohn C. S., Hasty S. E., Dalrymple J. M. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine. 10:1992;10-13.
26. Schmaljohn C., Hjelle B. Hantaviruses: A global disease problem. Emerg. Infect. Dis. 3:1997;95-104.
27. Schmaljohn C. S., Jennings G. B., Hay J., Dalrymple J. M. Coding strategy of the S genome segment of Hantaan virus. Virology. 155:1986;633-643.
28. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:1997;9563-9569.
29. Song G., Huang Y. C., Hang C. S., Hao F. Y., Li D. X., Zheng X. L., Liu W. M., Li S. L., Huo Z. W., Huei L. J., Zhang Q. F. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine. 10:1992;214-216.
30. Takenaka A., Gibbs C. J. Jr., Gajdusek D. C. Antiviral neutralizing antibody to Hantaan virus as determined by plaque reduction technique. Arch. Virol. 84:1985;197-206.
31. Ulrich R., Lundkvist Å., Meisel H., Koletzki D., Brus-Sjölander K., Gelderblom H. R., Borisova G., Schnitzler P., Darai G., Kruger D. H. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine. 16:1998;272-280.
32. Xu X., Ruo S. L., McCormick J. B., Fisher-Hoch S. P. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. Am. J. Trop. Med. Hyg. 47:1992;397-404.
33. Yoshimatsu K., Yoo Y. C., Yoshida R., Ishihara C., Azuma I., Arikawa J. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch. Virol. 130:1993;365-376.